INOVIQ LTD revenue for the last year amounted to 398.19 k AUD, the most of which — 363.21 k AUD — came from its highest performing source at the moment, Human Telomerase Reverse Transcriptase, the year earlier bringing 273.90 k AUD. The greatest contribution to the revenue figure was made by South Korea — last year it brought INOVIQ LTD 240.68 k AUD, and the year before that — 2.85 k AUD.